STOCK TITAN

[Form 4] Timberland Bancorp Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Robert A. Drugge, a director of Timberland Bancorp Inc. (TSBK), reported transactions on 08/13/2025 that changed his direct holdings. The filing shows an acquisition of 2,000 common shares at $10.71 per share, bringing his reported direct common-stock holdings to 38,245 shares. The report also records derivative activity tied to stock options: 2,000 options were acquired and the filing shows 14,600 options held following the transaction.

The filing notes a position of 6,773 shares identified with a footnote that they are held directly through an IRA. The disclosure was made by a single reporting person and was submitted via a power of attorney representative.

Robert A. Drugge, membro del consiglio di Timberland Bancorp Inc. (TSBK), ha dichiarato operazioni il 08/13/2025 che hanno modificato le sue partecipazioni dirette. La segnalazione riporta l'acquisto di 2,000 azioni ordinarie a $10.71 per azione, portando le sue partecipazioni dirette in azioni ordinarie dichiarate a 38,245 azioni. Il rapporto registra inoltre attività su strumenti derivati legate alle stock option: sono state acquisite 2,000 opzioni e il documento indica che risultano detenute 14,600 opzioni dopo la transazione.

La comunicazione segnala una posizione di 6,773 azioni accompagnata da una nota che specifica che sono detenute direttamente tramite un IRA. La divulgazione è stata effettuata da una sola persona segnalante ed è stata presentata tramite un rappresentante munito di procura.

Robert A. Drugge, miembro del consejo de Timberland Bancorp Inc. (TSBK), informó operaciones el 08/13/2025 que modificaron sus participaciones directas. La presentación muestra la adquisición de 2,000 acciones ordinarias a $10.71 por acción, elevando sus participaciones directas en acciones ordinarias reportadas a 38,245 acciones. El informe también registra actividad en derivados vinculada a opciones sobre acciones: se adquirieron 2,000 opciones y la presentación indica que quedan 14,600 opciones tras la transacción.

La presentación señala una posición de 6,773 acciones identificada con una nota que precisa que están retenidas directamente a través de una IRA. La divulgación fue realizada por una única persona informante y fue presentada mediante un apoderado.

Timberland Bancorp Inc. (TSBK)의 이사인 Robert A. Drugge는 08/13/2025에 그의 직접 보유 지분을 변경한 거래를 보고했습니다. 제출서에는 주당 $10.71에 보통주 2,000주를 취득한 것으로 기재되어 그의 신고된 직접 보통주 보유가 38,245주가 되었습니다. 보고서에는 또한 스톡옵션과 관련된 파생상품 활동이 기록되어 있으며: 옵션 2,000건을 취득했고 제출서에는 거래 후 14,600건의 옵션을 보유하고 있는 것으로 나타납니다.

제출서에는 각주로 표시된 6,773주의 포지션이 있으며, 이는 IRA를 통해 직접 보유된 것이라고 명시되어 있습니다. 이 공시는 단일 신고인에 의해 이루어졌으며 위임장을 가진 대리인을 통해 제출되었습니다.

Robert A. Drugge, administrateur de Timberland Bancorp Inc. (TSBK), a déclaré des opérations le 08/13/2025 qui ont modifié ses participations directes. Le dépôt indique l'acquisition de 2,000 actions ordinaires à $10.71 par action, portant ses participations directes en actions ordinaires déclarées à 38,245 actions. Le rapport enregistre également une activité sur dérivés liée à des options sur actions : 2,000 options ont été acquises et le dépôt montre 14,600 options détenues après la transaction.

Le dossier note une position de 6,773 actions identifiée par une note précisant qu'elles sont détenues directement via un IRA. La divulgation a été effectuée par une seule personne déclarante et a été soumise par l'intermédiaire d'un mandataire muni d'une procuration.

Robert A. Drugge, ein Direktor von Timberland Bancorp Inc. (TSBK), meldete am 08/13/2025 Transaktionen, die seine direkten Beteiligungen veränderten. Die Einreichung weist den Erwerb von 2,000 Stammaktien zum Preis von $10.71 je Aktie aus, wodurch sein gemeldeter direkter Stammaktienbestand auf 38,245 Aktien ansteigt. Der Bericht verzeichnet außerdem derivative Aktivitäten im Zusammenhang mit Aktienoptionen: 2,000 Optionen wurden erworben und in der Einreichung sind nach der Transaktion 14,600 Optionen aufgeführt.

Die Einreichung vermerkt eine Position von 6,773 Aktien, die mit einer Fußnote versehen ist, dass sie direkt über ein IRA gehalten werden. Die Offenlegung erfolgte durch eine einzelne meldende Person und wurde über einen bevollmächtigten Vertreter eingereicht.

Positive
  • Acquisition of 2,000 common shares at $10.71, increasing direct holdings to 38,245 shares
  • Reported acquisition of 2,000 stock options and 14,600 options held following the transaction
Negative
  • Disposition/notation of 6,773 shares identified with a footnote as held through an IRA

Insights

TL;DR: Director Drugge increased direct equity exposure by acquiring 2,000 shares and holds significant outstanding options.

The report documents a purchase of 2,000 common shares at $10.71 and concurrent derivative reporting showing 2,000 options acquired and 14,600 options owned after the transaction. For investors, insider purchases can signal confidence, but the filing does not disclose aggregate stake relative to shares outstanding or the company’s market capitalization, limiting assessment of materiality. The reported 6,773-share IRA position is noted separately and does not change the direct-holding disclosure.

TL;DR: Transaction reporting is routine and properly discloses direct and derivative holdings, with an IRA footnote for certain shares.

The Form 4 lists the reporting person as a director and records both non-derivative and derivative movements on 08/13/2025, including direct ownership of 38,245 shares after the reported activity and 14,600 options outstanding. The presence of a power of attorney signing the form is disclosed. There are no governance red flags in the disclosure itself; it provides clear counts and a footnote that 6,773 shares are held through an IRA.

Robert A. Drugge, membro del consiglio di Timberland Bancorp Inc. (TSBK), ha dichiarato operazioni il 08/13/2025 che hanno modificato le sue partecipazioni dirette. La segnalazione riporta l'acquisto di 2,000 azioni ordinarie a $10.71 per azione, portando le sue partecipazioni dirette in azioni ordinarie dichiarate a 38,245 azioni. Il rapporto registra inoltre attività su strumenti derivati legate alle stock option: sono state acquisite 2,000 opzioni e il documento indica che risultano detenute 14,600 opzioni dopo la transazione.

La comunicazione segnala una posizione di 6,773 azioni accompagnata da una nota che specifica che sono detenute direttamente tramite un IRA. La divulgazione è stata effettuata da una sola persona segnalante ed è stata presentata tramite un rappresentante munito di procura.

Robert A. Drugge, miembro del consejo de Timberland Bancorp Inc. (TSBK), informó operaciones el 08/13/2025 que modificaron sus participaciones directas. La presentación muestra la adquisición de 2,000 acciones ordinarias a $10.71 por acción, elevando sus participaciones directas en acciones ordinarias reportadas a 38,245 acciones. El informe también registra actividad en derivados vinculada a opciones sobre acciones: se adquirieron 2,000 opciones y la presentación indica que quedan 14,600 opciones tras la transacción.

La presentación señala una posición de 6,773 acciones identificada con una nota que precisa que están retenidas directamente a través de una IRA. La divulgación fue realizada por una única persona informante y fue presentada mediante un apoderado.

Timberland Bancorp Inc. (TSBK)의 이사인 Robert A. Drugge는 08/13/2025에 그의 직접 보유 지분을 변경한 거래를 보고했습니다. 제출서에는 주당 $10.71에 보통주 2,000주를 취득한 것으로 기재되어 그의 신고된 직접 보통주 보유가 38,245주가 되었습니다. 보고서에는 또한 스톡옵션과 관련된 파생상품 활동이 기록되어 있으며: 옵션 2,000건을 취득했고 제출서에는 거래 후 14,600건의 옵션을 보유하고 있는 것으로 나타납니다.

제출서에는 각주로 표시된 6,773주의 포지션이 있으며, 이는 IRA를 통해 직접 보유된 것이라고 명시되어 있습니다. 이 공시는 단일 신고인에 의해 이루어졌으며 위임장을 가진 대리인을 통해 제출되었습니다.

Robert A. Drugge, administrateur de Timberland Bancorp Inc. (TSBK), a déclaré des opérations le 08/13/2025 qui ont modifié ses participations directes. Le dépôt indique l'acquisition de 2,000 actions ordinaires à $10.71 par action, portant ses participations directes en actions ordinaires déclarées à 38,245 actions. Le rapport enregistre également une activité sur dérivés liée à des options sur actions : 2,000 options ont été acquises et le dépôt montre 14,600 options détenues après la transaction.

Le dossier note une position de 6,773 actions identifiée par une note précisant qu'elles sont détenues directement via un IRA. La divulgation a été effectuée par une seule personne déclarante et a été soumise par l'intermédiaire d'un mandataire muni d'une procuration.

Robert A. Drugge, ein Direktor von Timberland Bancorp Inc. (TSBK), meldete am 08/13/2025 Transaktionen, die seine direkten Beteiligungen veränderten. Die Einreichung weist den Erwerb von 2,000 Stammaktien zum Preis von $10.71 je Aktie aus, wodurch sein gemeldeter direkter Stammaktienbestand auf 38,245 Aktien ansteigt. Der Bericht verzeichnet außerdem derivative Aktivitäten im Zusammenhang mit Aktienoptionen: 2,000 Optionen wurden erworben und in der Einreichung sind nach der Transaktion 14,600 Optionen aufgeführt.

Die Einreichung vermerkt eine Position von 6,773 Aktien, die mit einer Fußnote versehen ist, dass sie direkt über ein IRA gehalten werden. Die Offenlegung erfolgte durch eine einzelne meldende Person und wurde über einen bevollmächtigten Vertreter eingereicht.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DRUGGE ROBERT A

(Last) (First) (Middle)
624 SIMPSON AVENUE

(Street)
HOQUIAM WA 98550

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TIMBERLAND BANCORP INC [ TSBK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.01 par value(1) 08/13/2025 M 2,000 A $10.71 38,245 D
Common Stock, $.01 par value 6,773(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $10.71 08/13/2025 M 2,000 09/22/2015 09/22/2025 Common Stock 2,000 $0 14,600 D
Explanation of Responses:
1. Shares held directly through an IRA.
/s/Cheryl Parks, Power of Attorney for Robert A. 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Timberland Bancorp (TSBK) director Robert A. Drugge report on the Form 4?

He reported acquiring 2,000 common shares at $10.71, holding 38,245 shares directly after the transaction, and reporting derivative holdings of 14,600 options.

When did the reported transactions for Robert A. Drugge occur?

The transactions are recorded with a transaction date of 08/13/2025.

How many stock options does the Form 4 show Robert A. Drugge owning after the transaction?

The Form 4 shows 14,600 derivative securities (stock options) beneficially owned following the reported transactions.

What is the significance of the 6,773 shares noted on the Form 4?

The filing footnote states those 6,773 shares are held directly through an IRA.

Who signed the Form 4 on behalf of Robert A. Drugge?

The form bears a signature by Cheryl Parks, Power of Attorney for Robert A. Drugge.
Timberland Bncp

NASDAQ:TSBK

TSBK Rankings

TSBK Latest News

TSBK Latest SEC Filings

TSBK Stock Data

263.48M
7.29M
7.19%
65.34%
0.5%
Banks - Regional
Savings Institutions, Not Federally Chartered
Link
United States
HOQUIAM